Literature DB >> 23204089

The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma.

Joel B Epstein1, Pelin Güneri, Hayal Boyacioglu, Elliot Abt.   

Abstract

BACKGROUND: The clinical oral examination (COE) is the criterion standard for the initial detection of oral lesions that harbor dysplasia or oral squamous cell carcinoma (OSCC) at an early stage when they are most treatable. The authors conducted a systematic review to assess the effectiveness of the COE in predicting histologic diagnosis of dysplasia or OSCC.
METHODS: The authors conducted automated searches of PubMed, Web of Knowledge and the Cochrane Library from 1966 through 2010 for randomized controlled trials and observational studies that included the terms "oral mucosal lesion screening" and "oral lesions." They determined the quality (sensitivity, specificity, positive predictive value, negative predictive value and diagnostic odds ratio) of selected studies by using the Quality Assessment of Diagnostic Accuracy Studies tool.
RESULTS: The overall diagnostic odds ratio was 6.1 (95 percent confidence interval, 2.1-17.6); therefore, the COE was considered to have poor overall performance as a diagnostic method for predicting dysplasia and OSCC. CLINICAL IMPLICATIONS: On the basis of the available literature, the authors determined that a COE of mucosal lesions generally is not predictive of histologic diagnosis. The fact that OSCCs often are diagnosed at an advanced stage of disease indicates the need for improving the COE and for developing adjuncts to help detect and diagnose oral mucosal lesions.

Entities:  

Mesh:

Year:  2012        PMID: 23204089     DOI: 10.14219/jada.archive.2012.0096

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  33 in total

Review 1.  Improving Oral Cancer Outcomes with Imaging and Artificial Intelligence.

Authors:  B Ilhan; K Lin; P Guneri; P Wilder-Smith
Journal:  J Dent Res       Date:  2020-03       Impact factor: 6.116

2.  Development of a multimodal foveated endomicroscope for the detection of oral cancer.

Authors:  Adam Shadfan; Hawraa Darwiche; Jesus Blanco; Ann Gillenwater; Rebecca Richards-Kortum; Tomasz S Tkaczyk
Journal:  Biomed Opt Express       Date:  2017-02-14       Impact factor: 3.732

Review 3.  Screening for Cancer in Persons Living with HIV Infection.

Authors:  James J Goedert; H Dean Hosgood; Robert J Biggar; Howard D Strickler; Charles S Rabkin
Journal:  Trends Cancer       Date:  2016-08

4.  Narrow band imaging observed oral mucosa microvasculature as a tool to detect early oral cancer: an Indian experience.

Authors:  Deepa Nair; Burhanuddin Qayyumi; Florida Sharin; Manish Mair; Munita Bal; Sharmila Pimple; Gauravi Mishra; Sudhir Nair; Pankaj Chaturvedi
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-09       Impact factor: 2.503

Review 5.  Epidemiologic trends in head and neck cancer and aids in diagnosis.

Authors:  Nadarajah Vigneswaran; Michelle D Williams
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-05       Impact factor: 2.802

6.  In Vivo Multimodal Optical Imaging: Improved Detection of Oral Dysplasia in Low-Risk Oral Mucosal Lesions.

Authors:  Eric C Yang; Richard A Schwarz; Alexander K Lang; Nancy Bass; Hawraa Badaoui; Imran S Vohra; Katelin D Cherry; Michelle D Williams; Ann M Gillenwater; Nadarajah Vigneswaran; Rebecca R Richards-Kortum
Journal:  Cancer Prev Res (Phila)       Date:  2018-06-14

7.  Risk Stratification System for Oral Cancer Screening.

Authors:  Lutécia H Mateus Pereira; Isildinha M Reis; Erika P Reategui; Claudia Gordon; Sandra Saint-Victor; Robert Duncan; Carmen Gomez; Stephanie Bayers; Penelope Fisher; Aymee Perez; W Jarrard Goodwin; Jennifer J Hu; Elizabeth J Franzmann
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-28

8.  Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

Authors:  Anil K Chaturvedi; Natalia Udaltsova; Eric A Engels; Jed A Katzel; Elizabeth L Yanik; Hormuzd A Katki; Mark W Lingen; Michael J Silverberg
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

Review 9.  The contribution of artificial intelligence to reducing the diagnostic delay in oral cancer.

Authors:  Betul Ilhan; Pelin Guneri; Petra Wilder-Smith
Journal:  Oral Oncol       Date:  2021-03-09       Impact factor: 5.337

10.  The use of Velscope to assess cellular changes occuring in oral premalignancy.

Authors:  Sonal Shah; Pushkar Waknis; Aditi Saha; Sneha Setiya; Tusha Ratra; Vibha Vaswani
Journal:  J Oral Biol Craniofac Res       Date:  2020-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.